异基因造血干细胞移植治疗骨髓纤维化研究进展
摘要
异基因造血干细胞移植（allo—HSCT）是唯一可治愈骨髓纤维化（MF）的途径。本文从移植适应症、移植时机与疗效、影响疗效的因素、移植后复发的处理几方面进行综述。
出处
《国际输血及血液学杂志》
CAS
2011年第3期217-221,共5页
International Journal of Blood Transfusion and Hematology
基金
基金项目：天津市自然基金（10JCYBJC13100
09JCYBJC11000）,教育部博士点新教师基金20080231133
参考文献26
-
1Cervantes F,Dupriez B,Pereira A.et al.New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment.Blood,2009,113(13):2895-2901.
-
2Dupriez B,Morel P,Demory JL,et al.Prognostic factors in agnogenic myeloid metaplasia:a report on 195 cases with a new scoring system.Blood,1996,88(3):l013-1018.
-
3Tefferi A.Allogeneic hematopoietic cell transplantation versus drugs in myelofibrosis:the risk-benefit balancing act.Bone Marrow Transplant,2010,45(3):419-421.
-
4Samuelson S,Sandmaier BM,Heslop HE,et al.Allogeneic haematopoietic cell transplantation for myelofibrosis in 30 patients 60-78 years of age.Br J Haematol,2011,153(1):76-82.
-
5Alchalby H,Kr(o)ger N.Reduced-intensity conditioning followed by allogeneic hematopoietic stem cell transplantation in myelofibrosis.Curr Hematol Malig Rep,2010,5(2):53-61.
-
6Ballen KK,Shrestha S,Sobocinski KA,et al.Outcome of transplantation for myelofibrosis.Biol Blood Marrow Transplant,2010,16(3):358-367.
-
7Lissandre S,Bay JO,Cahn JY,et al.Retrospective study of allogeneic haematopoietic stem-cell transplantation for myelofibrosis.Bone Marrow Transplant,2011,46(4):557-561.
-
8Kroger N,Holler E,Kobbe G,et al.Allogeneic stem cell transplantation after reduced-intensity conditioning in patients with myelofibrosis:a prospective,multicenter study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.Blood,2009,114(26):5264-5270.
-
9Robin M,Tabrizi R,Mohty M,et al.Allogeneic haematopoietic stem cell transplantation for myelofibrosis:a report of the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire (SFGM-TC).Br J Haematol,2010,152(3):331-339.
-
10Kr(o)ger N,Thielec J,Zandera A,et al.Rapid regression of bone marrow fibrosis after dose-reduced allogeneic stem cell transplantation in patients with primary myelofibrosis.Exp Hematol,2007,35(11):1719-1722.
-
1陈佳,吴德沛.异基因造血干细胞移植治疗慢性淋巴细胞白血病的研究进展[J].中华器官移植杂志,2012,33(7):444-446. 被引量：2
-
2黄文荣,于力.适合造血干细胞移植多发性骨髓瘤患者的治疗[J].中国实验血液学杂志,2011,19(1):249-253. 被引量：3
-
3《儿童恶性血液病脐带血移植专家共识》发布[J].中华医学信息导报,2016,31(23):9-9.
-
4殷晓芳.脐血干细胞移植治疗血红蛋白病[J].国外医学（输血及血液学分册）,1998,21(4):248-250.
-
5许兰平,刘开彦,陈欢,刘代红,韩伟,陈育红,高志勇,路瑾,王景枝,陆道培,黄晓军.异基因造血干细胞移植治疗骨髓增生异常综合征30例分析[J].中华血液学杂志,2006,27(8):518-521. 被引量：17
-
6张桂新(综述),冯四洲(审校).造血干细胞移植治疗骨髓增生异常综合征的研究进展[J].白血病．淋巴瘤,2009,18(7):437-440.
-
7王健民.异基因造血干细胞移植治疗骨髓增生异常综合征新进展[J].中华移植杂志（电子版）,2011,5(4):41-44.
-
8中国异基因造血干细胞移植治疗血液系统疾病专家共识（Ⅰ）——适应证、预处理方案及供者选择（2014年版）[J].中华血液学杂志,2014,35(8):775-780. 被引量：87
-
9丁家华,余正平,陈宝安,李玉峰,丁邦和,钱军,曹祥山.96例异基因造血干细胞移植后5年总生存率的危险因素分析[J].中国实验血液学杂志,2009,17(3):713-718. 被引量：2
-
10武大林,曹琼,陆洁,张泓,张志梅,丁红.应用细胞板、抗原板和混合抗原板检测HLA抗体及其临床意义[J].临床输血与检验,2000,2(3):30-31.
